Arcutis Biotherapeutics (ARQT) Earnings Date, Estimates & Call Transcripts → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free ARQT Stock Alerts $8.88 -0.28 (-3.06%) (As of 05/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 14) -$0.32 Beat By $0.28 Consensus EPS (May. 14) -$0.60 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Arcutis Biotherapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ARQT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueARQT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARQT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. Arcutis Biotherapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($1.60) EPSNext Year EPS Consensus Estimate: ($1.13) EPSARQT Earnings Date and InformationArcutis Biotherapeutics last announced its earnings data on May 14th, 2024. The reported ($0.32) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.60) by $0.28. The firm earned $49.57 million during the quarter. Arcutis Biotherapeutics has generated ($2.93) earnings per share over the last year (($2.93) diluted earnings per share). Earnings for Arcutis Biotherapeutics are expected to grow in the coming year, from ($1.60) to ($1.13) per share. Arcutis Biotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Arcutis Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/14/2024Q1 2024($0.60)($0.32)+$0.28($0.32)-$49.57 million 2/27/2024Q4 2023($0.64)($0.72)($0.08)($0.72)$11.78 million$13.53 million 11/3/2023Q3 2023($0.90)($0.73)+$0.17($0.73)$9.54 million$38.11 million8/8/2023Q2 2023($1.22)($1.16)+$0.06($1.16)$4.87 million$5.19 million5/9/2023Q1 2023($1.30)($1.31)($0.01)($1.31)$3.50 million$2.78 million2/28/2023Q4 2022($1.37)($1.18)+$0.19($1.18)$2.84 million$2.96 million Get the Latest News and Ratings for ARQT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022($1.54)($1.89)($0.35)($1.89)$1.01 million$0.73 million8/4/2022Q2 2022($1.38)($1.31)+$0.07($1.31)--5/5/2022Q1 2022($1.42)($1.27)+$0.15($1.27)--2/22/2022Q4 2021($1.41)($1.42)($0.01)($1.42)--11/4/2021Q3 2021($1.15)($1.14)+$0.01($1.14)--8/5/2021Q2 2021($0.94)($0.84)+$0.10($0.84)--5/3/2021Q1 2021($0.96)($0.76)+$0.20($0.76)--2/15/2021Q4 2020($0.88)($0.79)+$0.09($0.79)--11/5/2020Q3 2020($0.90)($1.01)($0.11)($1.01)-- 8/11/2020Q2($0.8430)($0.94)($0.0970)($0.94)--5/12/2020Q1($0.92)($1.15)($0.23)($1.15)--3/19/2020Q4 2019-($6.13)($6.13)($6.13)-- Arcutis Biotherapeutics Earnings - Frequently Asked Questions When is Arcutis Biotherapeutics's earnings date? Arcutis Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on ARQT's earnings history. Did Arcutis Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Arcutis Biotherapeutics (NASDAQ:ARQT) reported ($0.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.60) by $0.28. Learn more on analysts' earnings estimate vs. ARQT's actual earnings. How can I listen to Arcutis Biotherapeutics's earnings conference call? The conference call for Arcutis Biotherapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Arcutis Biotherapeutics's conference call transcript? The conference call transcript for Arcutis Biotherapeutics's latest earnings report can be read online. Read Transcript How can I view Arcutis Biotherapeutics's earnings report? Arcutis Biotherapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Arcutis Biotherapeutics generate each year? Arcutis Biotherapeutics (NASDAQ:ARQT) has a recorded annual revenue of $59.61 million. How much profit does Arcutis Biotherapeutics generate each year? Arcutis Biotherapeutics (NASDAQ:ARQT) has a recorded net income of -$262.14 million. ARQT has generated -$2.93 earnings per share over the last four quarters. What is Arcutis Biotherapeutics's EPS forecast for next year? Arcutis Biotherapeutics's earnings are expected to grow from ($1.60) per share to ($1.13) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Innoviva Earnings Results Ocular Therapeutix Earnings Results Kiniksa Pharmaceuticals Earnings Results Phathom Pharmaceuticals Earnings Results Supernus Pharmaceuticals Earnings Results ORIC Pharmaceuticals Earnings Results Nkarta Earnings Results Karyopharm Therapeutics Earnings Results BioXcel Therapeutics Earnings Results Alkermes Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: TD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's Earnings This page (NASDAQ:ARQT) was last updated on 5/29/2024 by MarketBeat.com Staff From Our Partners4 Cryptos BETTER than BitcoinTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.